Factor | T CD3+ lymphocytes (IT/TM) | p | T CD8+ lymphocytes (IT/TM | p | |||
---|---|---|---|---|---|---|---|
Low | High | Low | High | ||||
Histological subtype | Common (n = 19) | 6 | 13 | 0.7 | 9 10 | 0.05 | |
Variant (n = 11) | 5 | 6 | 1 10 | ||||
In situ carcinoma | Absence (n = 25) | 11 | 14 | 0.1 | 8 17 | 0.6 | |
Presence (n = 5) | 0 | 5 | 2 3 | ||||
Vascular invasion | Absence (n = 13) | 3 | 10 | 0.3 | 1 12 | 0.02 | |
Presence (n = 17) | 8 | 9 | 9 8 | ||||
Stage pT | pT1 (n = 9) | 4 5 | 0.7 | 4 5 | 0.4 | ||
≥ pT2 (n = 21) | 7 14 | 6 15 | |||||
Lymph node extension | No (n = 12) | 6 | 6 | 0.2 | 5 7 | 0.4 | |
Yes (n = 13) | 3 | 10 | 3 10 |